Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric …
Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric …
H Sha, Z Zou, K Xin, X Bian, X Cai, W Lu, J Chen… - Journal of Controlled …, 2015 - Elsevier
Abstract Human tumors, including gastric cancer, frequently express high levels of
epidermal growth factor receptors (EGFRs), which are associated with a poor prognosis.
Targeted delivery of anticancer drugs to cancerous tissues shows potential in sparing
epidermal growth factor receptors (EGFRs), which are associated with a poor prognosis.
Targeted delivery of anticancer drugs to cancerous tissues shows potential in sparing
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Jason Lee
jason@pepmic.com
Pepmic Co., Ltdjason@pepmic.com
www.pepmic.com
评论
发表评论